4481-v Amyloid β-Protein (Human, 1-28)

Code:
4481-v
Name:
Amyloid β-Protein (Human, 1-28)
SP-28 (Human)
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys
(Trifluoroacetate Form)
(M.W. 3262.5) C145H209N41O46
Amyloidogenic Segment of Amyloid β-Protein
Package Price(Yen)
Vial 0.5 mg 15,000

main

Purity:
≧99.0% (HPLC)
Storage:
-20 ℃
Source:
Human

Solubility: H2O (0.1 mM)

more information

CAS Registry Number:
109770-29-8
Category:
Biologically Active Peptides

reference

  1. D.A. Kirschner, H. Inouye, L.K. Duffy, A. Sinclair, M. Lind, and D.J. Selkoe, Proc. Natl. Acad. Sci. U.S.A., 84, 6953 (1987). (Original; Amyloid-Like Fibril Formation)
  2. B. Klajnert, M. Cortijo-Arellano, J. Cladera, and M. Bryszewska, Biochem. Biophys. Res. Commun., 345, 21 (2006). (Amyloid Fibril Formation)
  3. A. Perálvarez-Marin, A. Barth, and A. Gräslund, J. Mol. Biol., 379, 589 (2008). (Amyloid Fibril Formation)
  4. N.G.N. Milton and J.R. Harris, Micron, 40, 800 (2009). (Amyloid Fibril Formation)
  5. T. Wasiak, M. Ionov, K. Nieznanski, H. Nieznanska, O. Klementieva, M. Granell, J. Cladera, J.-P. Majoral, A.M. Caminade, and B. Klajnert, Mol. Pharm., 9, 458 (2012). (Amyloid Fibril Formation & Neurotoxity)
  6. J.S. Whitson, D.J. Selkoe, and C.W. Cotman, Science, 243, 1488 (1989). (Pharmacol.)
  7. B.A. Yankner, L.K. Duffy, and D.A. Kirschner, Science, 250, 279 (1990). (Pharmacol.)